Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis

Clinica Chimica Acta

Volumn 386, Issue 1-2, 2007, Pages 76-81

  Lutteri, Laurence ^a   Malaise, Michel ^b   Chapelle, Jean Paul ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Anti cyclic citrullinated peptide antibodies; Anti keratin antibodies; Rheumatoid arthritis; Rheumatoid factor; Sensitivity; Specificity

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; KERATIN ANTIBODY; RHEUMATOID FACTOR;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SERUM;

ADULT; AGED; ANTIBODIES; ANTIBODY SPECIFICITY; ARTHRITIS, RHEUMATOID; BIOLOGICAL ASSAY; BIOLOGICAL MARKERS; EARLY DIAGNOSIS; FEMALE; HUMANS; KERATINS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PREDICTIVE VALUE OF TESTS; RHEUMATOID FACTOR; SENSITIVITY AND SPECIFICITY;

EID: 34548668915     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.08.002     Document Type: Article

References (27)

1. Lee D.M., and Weinblatt M.E. Rheumatoid arthritis. Lancet 358 (2001) 903-911
2. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (1988) 315-324
3. Egeland T., and Munthe E. The role of the laboratory in rheumatology. Rheumatoid factors. Clin Rheum Dis 9 (1983) 135-160
4. Kroot E.J., de Jong B.A., van Leeuwen M.A., et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 43 (2000) 1831-1835
5. Goldblatt F., and Isenberg D.A. New therapies for rheumatoid arthritis. Clin Exp Immunol 140 (2005) 195-204
6. van Boekel M.A., Vossenaar E.R., van den Hoogen F.H., and van Venrooij W.J. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 4 (2002) 87-93
7. Serre G., Vincent C., Fournie B., Lapeyre F., Soleilhavoup J.P., and Fournie A. Anti-stratum corneum antibody in the rat esophagus, anti-epidermal keratin and anti-epidermis autoantibodies in rheumatoid polyarthritis and other rheumatic diseases. Diagnostic value and basic aspects. Rev Rhum Mal Osteo-Artic 53 (1986) 607-614
8. Union A., Meheus L., Humbel R.L., et al. Identification of citrullinated rheumatoid arthritis-specific epitopes in natural filaggrin relevant for antifilaggrin autoantibody detection by line immunoassay. Arthritis Rheum 46 (2002) 1185-1195
9. Schellekens G.A., de Jong B.A., van den Hoogen F.H., van de Putte L.B., and van Venrooij W.J. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 101 (1998) 273-281
10. Schellekens G.A., Visser H., de Jong B.A., et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43 (2000) 155-163
11. Visser H., le Cessie S., Vos K., Breedveld F.C., and Hazes J.M. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 46 (2002) 357-365
12. Suzuki K., Sawada T., Murakami A., et al. High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis. Scand J Rheumatol 32 (2003) 197-204
13. van Venrooij W.J., Hazes J.M., and Visser H. Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth J Med 60 (2002) 383-388
14. Vasishta A. Diagnosing early-onset rheumatoid arthritis: the role of anti-CCP antibodies. Am Clin Lab 21 (2002) 34-36
15. Bizzaro N., Mazzanti G., Tonutti E., Villalta D., and Tozzoli R. Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 47 (2001) 1089-1093
16. Jansen A.L., van der Horst-Bruinsma I., van Schaardenburg D., van de Stadt R.J., de Koning M.H., and Dijkmans B.A. Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol 29 (2002) 2074-2076
17. Bas S., Genevay S., Meyer O., and Gabay C. Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology (Oxford) 42 (2003) 677-680
18. Dubucquoi S., Solau-Gervais E., Lefranc D., et al. Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases. Ann Rheum Dis 63 (2004) 415-419
19. van Gaalen F.A., Linn-Rasker S.P., van Venrooij W.J., et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 50 (2004) 709-715
20. Vittecoq O., Incaurgarat B., Jouen-Beades F., et al. Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis. Clin Exp Immunol 135 (2004) 173-180
21. Vallbracht I., Rieber J., Oppermann M., Forger F., Siebert U., and Helmke K. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis 63 (2004) 1079-1084
22. van Jaarsveld C.H., ter Borg E.J., Jacobs J.W., et al. The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis. Clin Exp Rheumatol 17 (1999) 689-697
23. Goldbach-Mansky R., Lee J., McCoy A., et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2 (2000) 236-243
24. Lee D.M., and Schur P.H. Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis 62 (2003) 870-874
25. Vincent C., Serre G., Fournie B., Fournie A., and Soleilhavoup J.P. Natural IgG to epidermal cytokeratins vs IgG to the stratum corneum of the rat oesophagus epithelium, so-called 'antikeratin antibodies', in rheumatoid arthritis and other rheumatic diseases. J Autoimmun 4 (1991) 493-505
26. Meyer O., Fabregas D., Cyna L., and Ryckewaert A. Anti-keratin antibodies. A marker of progressive rheumatoid arthritis. Rev Rhum Mal Osteo-Artic 53 (1986) 601-605
27. Zeng X., Ai M., Tian X., et al. Diagnostic value of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. J Rheumatol 30 (2003) 1451-1455